AstraZeneca Acquires KuDOS Pharmaceuticals For $210 Mil.

The purchase provides AstraZeneca’s oncology division with DNA repair inhibitors in clinical, preclinical development.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet